Robert H. Tamis, M.D.

Robert Tamis was born in New York City, educated at Duke University (elected to Sigma Xi, the national research society for his genetic research on the Fused Gene in the house mouse), received his medical education at NYU College of Medicine (President of the student body), did his internship at Bellevue Hospital in New York, and took his residency in obstetrics and gynecology at the New York Einstein College of Medicine. He came to Fort Huachuca, Arizona for two years of Army duty.

Dr. Tamis entered private practice in Phoenix, Arizona in 1963, continuing until retirement in 2005.  During those 42 years he not only had a very busy practice, his civic responsibilities found him on the boards of directors of multiple charities.  He taught and chaired the Southwest School for Medical Assistants, and he was Chairman of obstetrics and gynecology at two Phoenix hospitals.

Dr. Tamis was the first in the United States to develop innovative videotaping of obstetrical procedures which in turn led to changes that ended the restrictions prohibiting fathers in both the delivery room and operating rooms in Phoenix, Arizona.

In 1984, Dr. Tamis developed Arizona’s first successful In Vitro Fertilization program resulting in Arizona’s first “test-tube” baby in November of that year, and his facility was the first In Vitro Fertilization facility in Arizona to be recognized by the Society for Assisted Reproductive Technology.  He has authored numerous papers on obstetrics and In Vitro Fertilization, and has lectured nationally on medical issues, especially misdiagnosis in medicine and proper treatment of gynecological cancers. 

Since 2001 Dr. Tamis has chaired the International Physicians Advisory Council (IPAC) of the International Cancer Advocacy Network.  Through his work with ICAN, he saw the inefficiency of the present clinical trial recruitment process.  Noting the failure of a previous attempt to modify the system to improve patient access to clinical trials, Dr. Tamis totally revamped the present archaic procedures to an innovative and revolutionary method of matching patients to clinical trials, resulting in the revolutionary Remission Coach® which ICAN hopes to launch in the near future.
IPAC was formed soon after the creation of ICAN as both an information resource as well as a source of referrals for those patients seeking second opinions.  Membership in IPAC is graced by some of the leading oncologic physicians throughout the world, encompassing all subspecialties in cancer treatment and molecular biology.

Personally touched by cancer, Dr. Tamis lost his wife, Beverlee, in 2012, after a long struggle with primary peritoneal carcinoma. His eldest daughter, Wendy, is a 12-year survivor of ovarian cancer. Spending precious time as father and grandfather to the five children and eleven grandchildren in his blended family of 29 years, Bob also enjoys—in addition to devoting many volunteer hours to IPAC and ICAN’s health information technology initiatives—traveling, designing and manufacturing jewelry, creating innovative photography, and painting with glass on glass, for which he has secured several commissioned works.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Search only trustworthy HONcode health websites:

Federal Tax I.D.: EIN 86-0818253 | CA Registry of Charitable Trusts: CT0208668 | WA Charities: 37195

This website provides information about ICAN® Personalized Medicine Cancer Case Navigation Programs, while it also describes the ICAN® multi-faceted mission, unique vision, and respected values. Intended for use by the general public. This site also offers more in-depth information for target populations who may benefit from ICAN® Program Services such as ICAN® patients, their caregivers and medical teams — along with those healthcare professionals and researchers who are involved with ICAN® medical and scientific councils.

The health news displayed on this site are chosen by our team of M.D.s, PhDs, and ICAN® President and CEO, who is an Affiliate Member of ASCO, Read more...

the American Society of Clinical Oncology; AMP, the Association for Molecular Pathology; and AACR, the American Association for Cancer Research.

Information contained herein is therefore not intended to substitute for or supersede any advice that a patient receives from his/her health professional and is not intended to compromise in any way the patient-physician relationship. ICAN® strongly believes that all medical decisions need to be made, via shared decision-making, by the patient and his/her medical team.